Clinical Trial Detail

NCT ID NCT02199236
Title Dose Escalation Trial of Endoluminal High-Dose-Rate Brachytherapy With Concurrent Chemotherapy for Rectal or Anal Cancer in Patients With Recurrent Disease or Undergoing Non-Operative Management
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Memorial Sloan-Kettering Cancer Center
Indications

rectum cancer

anus cancer

Therapies

Capecitabine + Fluorouracil

Age Groups: adult

No variant requirements are available.